Sign in
4

Changes in Ownership

PALVELLA THERAPEUTICS, INC. Filed Acc 0001104659-26-006237

Chief Operating Officer sold 4,302 shares at an average $97.63 ($419,983)

  • Chief Operating Officer acquired 4,302 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goin Kathleen · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-21 Exercise or conversion : show line 1 in the form 10b5-1 +2,154 $7.14 $15,380 2,154 D
2026-01-21 Exercise or conversion : show line 2 in the form 10b5-1 +2,148 $9.08 $19,504 4,302 D
2026-01-21 Sale : show line 3 in the form 10b5-1 −553 $95.49 $52,806 3,749 D
2026-01-21 Sale : show line 4 in the form 10b5-1 −3,749 $97.94 $367,177 0 D
Open-market sales · 4,302 sh · avg $97.63 · $419,983

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-21 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −2,154 19,397 D
2026-01-21 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −2,148 19,332 D
Loading xslF345X05/tm263925-1_4seq1.xml…